Status:

ACTIVE_NOT_RECRUITING

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Lead Sponsor:

The First Affiliated Hospital with Nanjing Medical University

Collaborating Sponsors:

Guangzhou Bruning Rock Bioengineering Ltd

Conditions:

Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

This study is a retrospective and prospective study aimed to develop and validate the performance of multi-omics assays for early detection of female breast cancer. The study will enroll approximately...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for All Participants:
  • Able to provide a written informed consent.
  • Female, at least 18 years old.
  • Additional Inclusion Criteria for Breast Cancer Participants:
  • Pathologically confirmed breast cancer diagnosis or highly suspicious for breast cancer within 42 days prior to blood draw.
  • No prior cancer treatment before the blood draw.
  • Additional Inclusion Criteria for Breast Benign Disease Participants:
  • Pathologically confirmed breast cancer diagnosis or highly suspicious of breast benign diseases within 90 days prior to blood draw.
  • No prior radical treatment before the blood draw.
  • Exclusion Criteria for All Participants:
  • During pregnancy or lactation.
  • Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant.
  • Recipient of blood transfusion within 7 days prior to blood draw.
  • Recipient of anti-tumor drugs to treat non-cancer diseases prior to blood draw, such as rheumatic drugs (methotrexate, cyclophosphamide, or azathioprine), or endocrine drugs (tamoxifen).
  • Additional Exclusion Criteria for Breast Cancer Participants:
  • Multiple primary tumors.

Exclusion

    Key Trial Info

    Start Date :

    July 10 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 30 2026

    Estimated Enrollment :

    496 Patients enrolled

    Trial Details

    Trial ID

    NCT06979921

    Start Date

    July 10 2021

    End Date

    December 30 2026

    Last Update

    August 14 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Jiangsu Provincial People's Hospital

    Nanjing, Jiangsu, China

    2

    The Affiliated Hospital of Medical College Qingdao University

    Qingdao, Shandong, China, 266100